Telazorlimab (GBR-830) is a humanized monoclonal antibody targeting the OX40 co-stimulatory receptor on activated T cells, and is used to treat lupus erythematosus and atopic dermatitis.
Purity:
>95%
CAS Number:
[2126777-87-3]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted